Literature DB >> 21607364

C-jun oncogene expression in nonsmall cell lung-cancer.

H Koutselini1, A Malliri, E Papadakis, D Gillespie, D Spandidos.   

Abstract

Primary lung cancer specimens of the non-small cell (NSC) types were examined for expression of the c-jun gene at the protein level by immunocytochemistry using the polyclonal antibody c-jun 890. The results obtained revealed that the c-jun p39 protein was expressed in 82% (18/22) of squamous cell carcinomas, 77% (10/15) of adenocarcinomas and 40% (2/5) of large cell anaplastic carcinomas, but no staining was seen in the non-cancer cases. Positive immunostaining was also seen in 16.7% (3/18) of the nonneoplastic bronchial cells of positively stained squamous cell carcinomas and in 40% (4/10) of adenocarcinomas. We suggest that elevated expression df c-jun p39 protein which was seen in a total of 75% (30/40) of the NSCLC, plays a role in lung cancer.

Entities:  

Year:  1994        PMID: 21607364

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  2 in total

1.  Chloroquine inhibits human CD4+ T-cell activation by AP-1 signaling modulation.

Authors:  Ralf L J Schmidt; Sabrina Jutz; Katrin Goldhahn; Nadine Witzeneder; Marlene C Gerner; Doris Trapin; Georg Greiner; Gregor Hoermann; Guenter Steiner; Winfried F Pickl; Heinz Burgmann; Peter Steinberger; Franz Ratzinger; Klaus G Schmetterer
Journal:  Sci Rep       Date:  2017-02-07       Impact factor: 4.379

2.  Identification of the anticancer effects of a novel proteasome inhibitor, ixazomib, on colorectal cancer using a combined method of microarray and bioinformatics analysis.

Authors:  Qiaowei Fan; Bingrong Liu
Journal:  Onco Targets Ther       Date:  2017-07-19       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.